C130H137Br3F22N20O5 — CID 158697751
3-bromo-5-fluoropyridine;4-[[4-[(5-bromo-3-pyridinyl)oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;2-bromo-5-(trifluoromethyl)pyridine;4-[(4-hydroxycyclohexyl)methyl]-2-(trifluoromethyl)benzonitrile;1-methylpiperazine;4-[[4-[[5-(4-methylpiperazin-1-yl)-3-pyridinyl]oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;4-[[4-[(5-piperazin-1-yl-3-pyridinyl)oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;2-(trifluoromethyl)-4-[[4-[[5-[4-[5-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]-3-pyridinyl]oxy]cyclohexyl]methyl]benzonitrile (PubChem CID 158697751) has the molecular formula C130H137Br3F22N20O5 and a molecular weight of 2717.33 g/mol. Its IUPAC name is 3-bromo-5-fluoropyridine;4-[[4-[(5-bromo-3-pyridinyl)oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;2-bromo-5-(trifluoromethyl)pyridine;4-[(4-hydroxycyclohexyl)methyl]-2-(trifluoromethyl)benzonitrile;1-methylpiperazine;4-[[4-[[5-(4-methylpiperazin-1-yl)-3-pyridinyl]oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;4-[[4-[(5-piperazin-1-yl-3-pyridinyl)oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;2-(trifluoromethyl)-4-[[4-[[5-[4-[5-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]-3-pyridinyl]oxy]cyclohexyl]methyl]benzonitrile.
| Compound Name | 3-bromo-5-fluoropyridine;4-[[4-[(5-bromo-3-pyridinyl)oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;2-bromo-5-(trifluoromethyl)pyridine;4-[(4-hydroxycyclohexyl)methyl]-2-(trifluoromethyl)benzonitrile;1-methylpiperazine;4-[[4-[[5-(4-methylpiperazin-1-yl)-3-pyridinyl]oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;4-[[4-[(5-piperazin-1-yl-3-pyridinyl)oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;2-(trifluoromethyl)-4-[[4-[[5-[4-[5-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]-3-pyridinyl]oxy]cyclohexyl]methyl]benzonitrile |
|---|---|
| PubChem CID | 158697751 |
| Molecular Formula | C130H137Br3F22N20O5 |
| Molecular Weight | 2717.33 g/mol |
| Exact Mass | 2712.83 |
| IUPAC Name | 3-bromo-5-fluoropyridine;4-[[4-[(5-bromo-3-pyridinyl)oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;2-bromo-5-(trifluoromethyl)pyridine;4-[(4-hydroxycyclohexyl)methyl]-2-(trifluoromethyl)benzonitrile;1-methylpiperazine;4-[[4-[[5-(4-methylpiperazin-1-yl)-3-pyridinyl]oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;4-[[4-[(5-piperazin-1-yl-3-pyridinyl)oxy]cyclohexyl]methyl]-2-(trifluoromethyl)benzonitrile;2-(trifluoromethyl)-4-[[4-[[5-[4-[5-(trifluoromethyl)-2-pyridinyl]piperazin-1-yl]-3-pyridinyl]oxy]cyclohexyl]methyl]benzonitrile |
| SMILES | CN1CCN(c2cncc(OC3CCC(Cc4ccc(C#N)c(C(F)(F)F)c4)CC3)c2)CC1.CN1CCNCC1.FC(F)(F)c1ccc(Br)nc1.Fc1cncc(Br)c1.N#Cc1ccc(CC2CCC(O)CC2)cc1C(F)(F)F.N#Cc1ccc(CC2CCC(Oc3cncc(Br)c3)CC2)cc1C(F)(F)F.N#Cc1ccc(CC2CCC(Oc3cncc(N4CCN(c5ccc(C(F)(F)F)cn5)CC4)c3)CC2)cc1C(F)(F)F.N#Cc1ccc(CC2CCC(Oc3cncc(N4CCNCC4)c3)CC2)cc1C(F)(F)F |
| InChI | InChI=1S/C30H29F6N5O.C25H29F3N4O.C24H27F3N4O.C20H18BrF3N2O.C15H16F3NO.C6H3BrF3N.C5H3BrFN.C5H12N2/c31-29(32,33)23-5-8-28(39-17-23)41-11-9-40(10-12-41)24-15-26(19-38-18-24)42-25-6-2-20(3-7-25)13-21-1-4-22(16-37)27(14-21)30(34,35)36;1-31-8-10-32(11-9-31)21-14-23(17-30-16-21)33-22-6-3-18(4-7-22)12-19-2-5-20(15-29)24(13-19)25(26,27)28;25-24(26,27)23-12-18(1-4-19(23)14-28)11-17-2-5-21(6-3-17)32-22-13-20(15-30-16-22)31-9-7-29-8-10-31;21-16-9-18(12-26-11-16)27-17-5-2-13(3-6-17)7-14-1-4-15(10-25)19(8-14)20(22,23)24;16-15(17,18)14-8-11(1-4-12(14)9-19)7-10-2-5-13(20)6-3-10;7-5-2-1-4(3-11-5)6(8,9)10;6-4-1-5(7)3-8-2-4;1-7-4-2-6-3-5-7/h1,4-5,8,14-15,17-20,25H,2-3,6-7,9-13H2;2,5,13-14,16-18,22H,3-4,6-12H2,1H3;1,4,12-13,15-17,21,29H,2-3,5-11H2;1,4,8-9,11-13,17H,2-3,5-7H2;1,4,8,10,13,20H,2-3,5-7H2;1-3H;1-3H;6H,2-5H2,1H3 |
| InChIKey | IHDSIPFOHMMWCX-UHFFFAOYSA-N |
| XLogP | 30.31 |
| TPSA | 309.83 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 180 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2717.33 |
| LogP ≤ 5 | 30.31 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 25 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|